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Quinolinic acid (pyridine 2,3-dicarboxylic acid) which is an immediate precursor of the pyridine 
nucleotides, is synthesised from L-aspartate and dihydroxyacetone phosphate in Escherichia coli. 
Extracts from certain nadB mutants complement the extracts prepared from all nadA mutants for the 
enzymic synthesis of quinolinate. Using the complementation assay, the quinolinate synthetase B 
protein has been purified more than 300-fold. The quinolinate synthetase B protein exists in all nadA 
and nadC mutants examined. The quinolinate synthetase A protein was present in all nadC mutants 
and most (but not all) nadB mutants. The facile separation of the wild-type quinolinate synthetase A 
and B proteins out of a nadC mutant suggests that quinolinate synthetase does not exist as a tightly 
bound complex. The partially purified quinolinate synthetase is inhibited by physiological concen- 
trations of NAD and NADH but not by NADP or NADPH. 
The pyridine nucleotides, nicotinamide-adenine 
dinucleotide (NAD) and nicotinamide-adenine di- 
nucleotide phosphate (NADP) are present in all living 
cells and serve as substrates for an unusually large 
and diverse number of cellular oxidative-reductive 
reactions. The biosynthetic sequence which produces 
the pyridine nucleotides in bacteria has not been 
characterized, although the tryptophan to quinolinic 
acid to NAD pathway is known to exist in mammals 
and fungi [1,2]. In prototrophic bacteria and plants, 
quinolinic acid is also an immediate precursor of 
the pyridine nucleotides [3,4] but the biosynthetic 
pathways from L-aspartic acid to quinolinate remain 
to be elucidated [5,6]. In aerobic species, the seven 
carbon atoms of quinolinic acid are derived from 
dihydroxyacetone phosphate and L-aspartate, while 
anaerobic species derive the carbon skeleton from 
N-formyl-L-aspartate and acetyl-coenzyme A [7 - 91. 
The enzymic synthesis of quinolinic acid in both 
wild-type and certain nicotinic-acid-requiring (nad-)- 
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strains of Escherichia coli has been described in cell- 
free extracts [6,8]. 
The biochemical genetics of strains of E. coli 
requiring nicotinic acid (or nicotinamide), which are 
referred to as nad mutants, have been extensively 
investigated. The nadA, nadB and nadC loci have 
been mapped by transduction and are located at 
approximately 17, 49 and 1.5 min on the E. coli 
chromosome, respectively [lo, 111. The nadC mutants 
lack significant amounts of the enzyme quinolinate 
phosphoribosyltransferase (decarboxylating), excrete 
excessive amounts of quinolinate into the growth 
medium and contain the enzyme(s) required for the 
synthesis of quinolinate from L-aspartate and triose 
phosphate [5,6,8]. These results support the hypo- 
thesis that the nadC locus codes for the structural 
gene for quinolinate phosphoribosyltransferase. The 
role of the nadA and nadB gene products remains to 
be clarified. These mutants will utilize quinolinate for 
growth, contain the enzyme quinolinate phospho- 
ribosyltransferase and do  not synthesize quinolinate 
in vitro, which suggests that nadA and nadB loci code 
for proteins in the quinolinate biosynthetic pathway 
[7,12]. The nadA and nadB gene products can be 
complementary, since quinolinate synthesis is observed 
when any nadA extract is added to certain nadB ex- 
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tracts, under the appropriate conditions [12]. However, 
other nadR extracts fail to complement with either 
any nadA extract or any nadB extract. No evidence for 
the accumulation of any intermediates between L- 
aspartate and quinolinate has been obtained in any 
nad mutant extract [7,12]. 
The observations could suggest that the complete 
reaction sequence from L-aspartate to quinolinate 
occurs on an enzyme complex composed of the nadA 
and nadB gene products. The non-complementary 
nadB mutants could then be explained by postulating 
that the mutant nudB gene product is produced in 
excess and is virtually irreversibly bound to the nadA 
gene product. Alternatively, the non-complementary 
nadB mutants, which have been referred to as nadR 
[12], may be regulatory mutants which fail to produce 
either the nadA protein or the nadB protein. These 
interrelationships are summarized in Fig. 1. 
In this paper we reported the purification of qui- 
nolinate synthetase B protein and its facile separation 
from the quinolinate synthetase A protein in extracts 
of nadC mutant. 
MATERIALS AND METHODS 
Bacterial Struins 
The bacterial strains used are listed in Table 1. 
Growth Conditions 
The minimal media of Yates and Pardee [13] 
supplemented with 0.5 pM nicotinic acid and other 
necessary growth factors were used. After harvesting 
the bacteria on a Sharples centrifuge, the cell paste 
was washed with saline and stored at -20 "C until 
used. The enzyme activity remained stable in the cells 
for more than 4 months. 
Preparation of Crude Extracts 
The crude extract of the E. coli K-12 PA-2-18 
used for enzlme purification was prepared by suspen- 
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sion of 60 g of frozen cells in 300 ml of 0.05 M Bicine 
buffer, pH 8.0. When a homogeneous suspension 
was obtained, a volume of 350 ml was sonicated for 
18 min at 0 - 4 "C in a large rosette cell with a Branson 
sonifier set at 10 A (D.C.). The sonicate was centri- 
fuged at 40000 x g for 45 min to remove cell debris, 
yielding about 325 ml of crude extract. 
Preparation of A Protein.for Assay 
of the B Protein 
In order to assay for the B protein it was necessary 
to prepare the relatively unstable A protein im- 
mediately prior to the assay. The A protein for the 
quinolinic acid synthesis assay was partially purified 
by heat treatment and salt fractionation from strain 
SB-16 before use in the assay. The crude extract, 
prepared as described above, was mixed for 5 rnin 
in a 55 "C water bath and subsequently cooled 10 rnin 
in a water-ice bath. After centrifugation for 15 rnin 
at 20000 x g, about SO ml of heat-treated supernatant 
were obtained. Solid ammonium sulfate was added 
gradually over 15 min to this supernatant and stirred 
at 0-4 "C to reach 4 0 7 ~  saturation of ammonium 
sulfate. After mixing for 30min, the solution was 
centrifuged at 20 000 x g for 15 min. The supernatant 
was treated with ammonium sulfate in the same 
manner to bring it to 60% saturation. After 30 rnin 
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mixing and 15 min centrifugation at 20000 x g, the 
supernatant was discarded and the pellet was re- 
dissolved in 0.005 M potassium phosphate buffer, 
pH 7.5, containing 0.05 M KC1 (0.2 ml/mg pellet). 
These steps result in a 7-fold final increase in the speci- 
fic activity of the A protein over the crude extract. 
Enzyme Assay for  Quinolinic Acid Synthesis 
Measurements of the enzymic activities of the 
A and B proteins were made using the procedures 
described by Suzuki et al. [7] and Chandler and Ghol- 
son [I41 with some modifications. 
Reaction mixtures were prepared as follows : 
each assay sample contained 0.25 pmol of L-aspartate, 
1 pmol of fructose 1,6-bisphosphate or dihydroxy- 
acetone phosphate, 0.01 pmol FAD, and 30 pmol of 
Bicine buffer, pH 8.0 (adjusted with KOH) in a volume 
of 0.1 ml. Also 0.1 ml of a 5-pCi/ml [U-14C]aspartic 
acid solution (specific activity 160 mCi/mmol) was 
added to each tube. Enzyme preparations totaling 
0.3 ml were added, making a final volume in the assay 
tubes of 0.5 ml. 
Assay of the B protein used an excess of the A 
protein such that the activity of the B protein limited 
the rate of quinolinic acid synthesis. Routinely, 0.2 ml 
of the 40-60% ammonium sulfate fraction from 
strain SB-16 and 0.1 ml of diluted B enzyme fraction 
were added to each assay tube. These volumes repre- 
sent 0.3 -0.5 mg and 0.01 - 3 mg protein, respectively. 
When activity of the A protein was measured, B pro- 
tein was added in excess as 0.1 ml of the 0-50% 
sodium citrate fraction and the A protein was added 
in a limiting amount. The use of fructose 1,6-bis- 
phosphate as a substrate necessitates the presence of 
adolase in the assay. This enzyme is present in the 
40 - 60 % ammonium sulfate fraction of the A protein 
preparation. 
The assay reaction was begun by adding the 
protein fraction which was to be in excess to the other 
assay components in order to make a complete mixture 
for quinolinic acid synthesis in vitro. After gentle 
mixing, tubes were incubated at room temperature 
(23 "C) without shaking. After 20 min, 0.5 ml of 15 % 
perchloric acid was added to stop the reaction. Then 
0.5 ml of 2 mM unlabeled quinolinic acid was added, 
and the tubes were centrifuged. After decantation, 
the supernatants were neutralized by addition of 
0.5 ml of 2.5 N KOH, with subsequent adjustment to 
pH 7.0 using indicator paper and were again centri- 
fuged. 
The [14C]quinolinic acid in these deproteinized 
and neutralized reaction mixtures was determined 
by a minor modification of the method of Chandler 
and Gholson [8,14]. 
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Fig. 2. The linear dependence of the rate of quinolinate synthesis on 
the concentration of the B protein. Aliquots of the 0- 50 % satura- 
tion sodium citrate fraction (7.35 mg/ml) were diluted from 1 : 10 
to 1 : 200 and assayed in duplicate. The measured quinolinate syn- 
thetase catalytic activity is plotted against the weight of B protein 
fraction added 
After purification by ion-exchange chromatog- 
raphy, a 2-ml aliquot of the eluate was counted in 
Bray's scintillation cocktail and the amount of quino- 
h a t e  synthesized (as nmol) calculated from the 
specific activity of the ~-[U-'~C]aspartate added. 
A unit of enzyme activity is defined as the amount of 
enzyme which forms 1 nmol of quinolinate from 
L-aspartate in 20 min at 23 "C under the conditions 
described. 
In order to estimate the amount of B protein 
present the amount of quinolinate synthesized should 
be a linear function of the amount of B protein added. 
This assay satisfied this requirement, as shown in 
Fig. 2. 
Protein Determination 
Protein was determined either by the method of 
Lowry et al. [15] or spectrophotometrically by the 
280/260-nm absorbance ratio [16]. 
Chemicals 
The L- [U-14C]aspartate (1 60 mCi/mmol) was ob- 
tained from New England Nuclear and from ICN- 
Isotope and Nuclear Division. All other chemicals 
were of reagent grade from local supply houses. 
NAD-agarose was obtained from P-L Biochemicals, 
Inc. 
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RESULTS 
Purification of the B Protein 
Step I. Protamine Suljatc Fractionation. Removal 
of nucleic acids was accomplished by addition of 
protamine sulfate to the crude extract. A 2 % (20 mg/ 
ml) suspension was prepared by adding 550 mg 
protamine sulfate to 27.4 ml 0.05 M potassium phos- 
phate. 2 mg protamine sulfate was used to every 10 mg 
crude extract protein. The suspension was added 
dropwise with mixing to 415 ml of crude extract kept 
at 0-4 "C. After the addition was complete and the 
mixture had been stirred another 30min, it was 
centrifuged for 15 min at 8000 xg. The pellet was 
discarded and 443 ml of supernatant were ready for 
further purification. At all purification steps, 0.5-ml 
or l-ml samples were removed and stored at - 15 "C 
for assay and protein determination. Frequently, 
the total activity recovered in the protamine sulfate 
supernatant was greater than the assayed activity in 
the crude extract. This activity enhancement may be 
due to the removal of inhibiting substances by pre- 
cipitation with the protamine sulfate. Routinely, this 
step resulted in recovery of total activity over 90% 
and a 1 - 3-fold increase in specific activity over that 
of the crude extract. 
Step II .  Sodium Citrate Fractionation. A saturated 
solution of sodium citrate was prepared at room 
temperature (23 "C) and adjusted to pH 7.0 with 
saturated citric acid. Then an equal volume (443 ml) 
of this solution was added dropwise to the 443 ml 
of protamine sulfate supernatant which was stirring 
at 0-4 "C. After completion of this addition and 
further mixing for 20 min, the suspension was centri- 
fuged 15 min at 8000 x g. The supernatant was dis- 
carded and the protein pellet was redissolved in 
11 - 12 ml 0.005 M potassium phosphate, pH 7.5, 
with a final volume of 23 ml. (Sodium citrate was 
found to inhibit the quinolinate synthesis assay and 
was removed by dialysis against 0.005 M potassium 
phosphate pH 7.5 before assay.) 
Step III .  Gel Filtration on Sephadex G-200. A 4.5 
x88-cm column packed at  4 'C with 1400ml of 
swelled, degassed Sephadex G-200 was equilibrated 
with 2 1 of 0.005 M potassium phosphate, pH 7.5. 
Then 22 ml of the 0- 50 saturation sodium citrate 
fraction was mixed with 1 ml of saturated sucrose 
solution and layered under the buffer on top of the 
gel bed. Elution was effected with 0.005 M potassium 
phosphate buffer, pH 7.5, using a 25-cm head and 
collecting 9-1111 fractions at 4 "C. Flow rate of the 
column was about 37 ml/h and the column was eluted 
within 40 h. Previous determinations of the behaviour 
of the B protein on Sephadex G-200 allowed pooling 
of fractions containing the B protein without first 
assaying the effluent. Fractions 68 to 140 were thus 
pooled, making the pooled eluate 650 ml in volume. 
Step IV.  Anion- Exchange Chromatography on 
DEAE-Seplzadex. A 4 x 13-cm column of DEAE- 
Sephadex was packed at 4 "C and equilibrated with 
700 ml of 0.005 M potassium phosphate, pH 7.5, 
and then 647ml of the pooled Sephadex G-200 
effluent was passed through the column. Monitoring 
the absorbance of the effluent at 280nm indicated 
that all of the protein was bound to the DEAE- 
Sephadex. The column was washed at 4 ° C  with 
0.20 M KC1 in 0.005 M potassium phosphate, pH 7.5. 
After 600 ml of elution, the protein had dropped to 
below 0.05 absorbance unit at  280 nm in the effluent. 
This wash was discarded and the column was eluted 
with 375 ml of 0.25 M KC1, 0.005 M potassium phos- 
phate buffer, pH 7.5, after which the protein absorb- 
ance was again reduced to 0.05 absorbance unit. This 
effluent was a fairly dilute protein solution, so 25-ml 
and 50-ml portions of glycerol, a stabilizing agent, 
were added as the 375-m1 effluent was collected. The 
solution was continuously stirred at 4 'C during 
collection and the final volume was 504 ml, containing 
25 % glycerol. 
Step V. Hy dr oxyapa t ite Chroma tograp hy . Further 
purification beyond the DEAE-Sephadex step in- 
volved low -protein concentrations and required the 
presence of 25% glycerol in all buffers to stabilize 
the B protein activity. A 1.9 x 30-cm column was 
packed with hydroxyapatite and equilibrated first 
with 500 ml of 0.005 M potassium phosphate, pH 7.5, 
and then 200 ml of 0.01 M potassium phosphate, 
pH 7.5. Both equilibrating solutions contained 25 
glycerol. Then 500 ml of the 0.25 M KCl DEAE- 
Sephadex effluent were passed through the column, 
and all the protein was bound to the hydroxyapatite. 
The B protein activity was subsequently eluted with 
0.01 M potassium phosphate, pH 7.5, in 25 7; glycerol, 
collecting 9.8-ml fractions. The protein peak as 
monitored by absorbance at 280 nm was pooled and 
resulted in 78 ml of protein solution. The low flow 
rate of 25 glycerol solution necessitated running 
this column at room temperature. 
The above purification scheme resulted in an over 
340-fold enrichment of specific activity with approx- 
imately a quarter of the enzyme activity being recover- 
ed from the crude extract, as summarized in Table 2. 
Stabilization 
of the Quinolinate Syzthetase A ard B Proteins 
by Glycerol 
During the course of the purification, it became 
apparent that the B protein catalytic activity was 
unstable in dilute protein solutions. Addition of 
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Table 2. Purificulion of the B protein of the quinolinate synthetase system in E. coli 
Step Total volume Total protein Total activity Specific activity Enrichment Recovery 
-fold % units k-units/mg ml mg 
Crude extract 416 111659 12242 1.05 3 100 
Protamine sulfate supernatant 443 5039 15514 3.08 2.9 127 
0- 50 % sodium citrate pellet 23 837.2 10803 12.9 12.3 88 
Sephadex G-200 (pooled fractions) 650 335.0 15 470 47.6 45.3 126 
DEAE-Sephadex (pooled fractions) 502 55.2 10542 191 182 86 
Hydroxyapatite (pooled fractions) 156 8.3 2 900 361 344 24 
Table 3. Purification of the A and Bproteinsfrom E. coli nadC mutant, E-126 
The purifications of the A and B proteins were conducted as described in Materials and Methods. E. coli strain E-126 is a nadC mutant which 
is wild-type at both the nadA and nadB loci 
Step Total volume Total protein Total activity Specific activity Enrichment Recovery 
ml mg units k-units/mg -fold % 
B protein 
Crude extract 194 4656 16 199 3.5 1 100 
Protamine sulfate supernatant 212 3 286 14522 4.4 1.3 89.6 
0- 50 ”/, citrate pellet 7.1 234 5 495 23.5 6.7 33.9 
DEAE-Cellulose 173 52 3 689 71.0 20.4 22.8 
(pooled fractions) 
A protein 
Crude extract 95 2 260 1000 0.44 1 100 
Heat treatment supernatant 93 2 840 804 0.28 0.6 80.4 
40 - 60 % ammonium sulfate 18.4 258 405 1.57 3.6 40.5 
glycerol greatly retarded the loss of activity at - 15 “C, 
4 “C and 23 “C and hence it was used in later purifica- 
tion steps. Addition of glycerol to form 33 % glycerol 
solutions of the A protein also stabilized the catalytic 
activity of the A protein for periods up to 10 days 
at - 15 “C. 
Separation of Quinolinate Synthetase 
into A and B Protein Components 
The complementary nature of nadA and nadB 
mutant extracts in quinolinate synthesis suggests 
that two independent enzymes may be required for 
the net reaction to occur [12]. On the other hand, the 
physical-chemical characteristics of the mutant en- 
zyme(s) may be dramatically different from the wild- 
type enzyme. It is conceivable that the mutant recovery 
procedure used during the mutagenesis experiments 
could select for complementary enzyme forms and 
hence introduce natural bias into the character of our 
mutants. The failure to detect any intermediates 
between L-aspartate and quinolinate suggests that a 
complex may be formed between the A protein and 
the B protein. In order to gain some information 
about the molecular nature of the native quinolinate 
synthetase system, the separation of the A protein 
from the B protein was investigated, starting with a 
nadC mutant which contains both activities. The 
results of this experiment are presented in Table 3. 
The salt fractionation employed to partially purify 
the B protein separates it from the A protein. The 
heat treatment of 55 “C used to partially purify the A 
protein inactivates the B protein. The results indicate 
that the two activities are readily separated from one 
another. These results suggest the nature of the 
A . B “complex” is such that the “complexed” forms 
are in rapid equilibrium with the free forms of the 
enzyme(s) and make it highly unlikely that the A 
and B proteins are covalently linked or otherwise 
tightly bound to one another in this nadC mutant 
which is wild-type at both the nadA and nadB loci. 
Quantitative Estimates 
of Quinolinate Synthetase A and B Protein Activities 
in nadA, nadB and nadC Mutants 
The original biochemical classification of quino- 
linate synthetase mutants into three distinct groups, 
two mutually complementing groups and one non- 
complementing group was based upon qualitative 
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Table 4. The specific activities of the quinolinate synthetase A and B 
proteins in nadA, nadB, nadR and nadC mutants 
The specific activity of the freshly prepared crude extracts was 
measured as described in Materials and Methods. The percentage 
activity is compared to the two standard reference mutants, PA-2-18 
and SB-16 
Mutant Specific activity Activity cf PA-2-18 
and SB-16 
A protein B protein A protein B protein 
k-unitshg % 
nodl 
PA-2-18 48.2 964 5.0 100 
AT-11-23 29.6 952 2.3 13.3 
nudB 
SB-16 1200 31.7 100 2.7 
w-3899 718 31.8 53.4 2.4 
nUdR 
E-18 86 40 
nadC 
15-126 3150 566 101.5 50.3 
SR-99 600 382 51.9 33.2 
W-4516 920 672 67.6 49.1 
enzyme activity measurements conducted with crude 
extracts [12]. Later, it became apparent that one of 
these groups of mutants correspond to the nadA 
genetic group. The other complementary group and 
the non-complementary group are closely linked at 
the nadB andjor nadR loci [12]. The quinolinate 
synthetase assay described in this paper is approxi- 
mately 10 times more sensitive than the former method 
using crude extracts. Thus, it was possible to re-ex- 
amine the original classification schemes using partially 
purified B to assay for the A protein and vice versa. 
The results, which are shown in Table 4, confirm the 
general character of the original classification scheme. 
However, in contrast to earlier results in crude 
extracts, strain W-3899, which was classified as a 
nadR mutant, is now shown to contain the A protein 
and is reclassified as a nadB mutant. The source of 
the experimental variation may be due to either the 
more sensitive assay employed or to further mutations 
in the strain in the six intervening years. 
Ejject o j  the Pjridine Nucleotides 
on Quinolimtr~ Synthesis 
The quinolinate synthetase system may be subject 
to both repression and feed-back inhibition [6,7]. 
In order to test this latter hypothesis the effect of the 
pyridine nucleotides on the partially purified system 
was investigated. Estimates of the intracellular concen- 
Table 5. The effect of pyridine nucleotides on quinolinate .synthetnse 
activity 
The pyridine nucleotides at the stated concentrations, were added to 
the standard assay described in the text. The B protein used was 
purified approximately 150-fold over the crude extract. Results 
are expressed as units/ml B protein fraction with percentage inhibi- 
tion (cf. control) in brackets 
Addition to 
assay pyridine nucleotide concn : 
Quinolinate synthetase activity (inhibition) at 
3.33 mM 1.0 mM 0.33 mM 
unitsiml (%) 
HzO 513 (0) 513 (0) 513 (0) 
NAD+ 22.6 (95.6) 237 (53.9) 437 (10.9) 
NADH 41.3 (92.0) 217 (57.8) 414 (19.2) 
NADP' 368 (28.3) 366 (28.6) 436 (15.0) 
NADPH 393 (23.5) 408 (20.5) 487 (5.0) 
tration of NAD in E. coli range from 0.3 mM to 
about 3 mM so this concentration range was studied 
[37- 191. The results, which are presented in Table 5, 
indicate that concentrations of NAD which approxi- 
mate the intracellular concentrations have a dramatic 
effect on the catalytic activity of quinolinate syn- 
thetase. Thus, this experimental evidence supports 
the hypothesis that this pathway is regulated by feed- 
back inhibition. In direct contrast to the results 
obtained with NAD, the experimental data suggest 
that NADP is not an effector in this system since only 
weak inhibition is obtained even at concentrations 
of NADP 10 times above the normal intracellular 
concentration. Consistent with the NAD inhibition 
data, we have observed the binding of the B protein 
to an NAD-agarose affinity column (G. R. Griffith 
and R. K. Gholson, unpublished observations). 
DISCUSSION 
In order to study the molecular mechanisms of 
NAD biosynthesis and its regulation, the individual 
components of the pathway must be isolated and 
characterized. 
The published experimental data do not provide 
a basis for determining the character of the enzymic 
system which synthesizes quinolinate from L-aspartate 
and dihydroxyacetone phosphate, although the over- 
all stoichiometry of the reaction has been established 
[7]. In this paper, we present evidence that two 
proteins which are easily separated are required for 
quinolinate synthesis. One of these proteins has been 
purified over 340-fold by salt fractionation, gel 
filtration and ion-exchange chromatography. The 
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existence of two protein fractions is consistent with 
the genetic observations of the nadA and nadB genes. 
All our nadA mutants contain an enzymically func- 
tional B protein. Mutants which map in the nadB 
region, however, may or may not contain the A pro- 
tein and have been classified as either nadB or nadR 
[12]. The nature of nadR remains to be established. 
The failure to detect any significant quinolinate 
synthetase A or B protein activity in the nadR strain 
can be equally explained by two independent hypo- 
theses. The first hypothesis is that a very tight, but 
inactive molecular complex is formed between the 
nadA and nadB gene products in the nadR mutant. 
In this case, the nadR mutation would reside within 
the structural portion of the nadB gene. The second 
hypothesis is that the nadR gene is a true regulator 
gene which regulates the expression of the non- 
contiguous nadA and nadB structural genes. The 
available biochemical evidence can not distinguish 
between these two postulates. The published genetic 
evidence has been interpreted in terms of the true 
regulatory gene hypothesis. Recently, Tritz [20] report- 
ed the isolation of a strain designated as nadR'lnadR 
transheterogenate and deduced from regulator gene 
theory that the nadR' gene is a positive regulator 
gene since it was trans dominant. The genetic evidence 
was not supported by chemical estimations of the 
enzyme activities involved. We now show that strain 
W-3899, (Tritz's strain UTH 4464) which was used 
to generate the putative nadR' /nadR transhetero- 
genote is, indeed, a nadB mutant (Table 3). Obviously, 
nadB'lnadB would be trans dominant and the conclu- 
sions drawn by Tritz need to be re-evaluated. The 
possibility that W-3899 has undergone further spon- 
taneous mutations (i.e. nadR -+ nadB in our laboratory 
or nadB + nadR in Dr Tritz's laboratory) must not 
be overlooked. 
The inhibition of quinolinate synthetase at con- 
centrations of NAD which approximate the normal 
physiological concentrations of NAD provides further 
support for the hypothesis that NAD is a feedback 
inhibitor for the pathway [6]. The observed binding 
of B protein (but not the A protein) of quinolinate 
synthetase to an NAD-agarose affinity column may 
suggest that the molecular site of NAD inhibition 
of the over-all reaction exists on the B protein of the 
quinolinate synthetase complex. 
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